Association between low estrogen receptor positive breast cancer and staining performance
Dennis L. Caruana(Yale University), Emily Reisenbichler(Saint Louis University)
Cited by 27
Related Papers
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
|JAMA Oncology|2022|347
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
|Modern Pathology|2021|166
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
|Modern Pathology|2023|98
Multi-institutional Assessment of Pathologist scoring HER2 Immunohistochemistry
|Research Square|2022|7
Deep learning trained on H&E tumor ROIs predicts HER2 status and Trastuzumab treatment response in HER2+ breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2021|3